FDA Drug Recalls

Recalls / Class II

Class IID-501-2013

Product

Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12

Brand name
Diazepam
Generic name
Diazepam
Active ingredient
Diazepam
Route
Intramuscular, Intravenous
NDC
0409-3213
FDA application
ANDA071583
Affected lot / code info
17-099-EV Exp 05/14

Why it was recalled

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Recalling firm

Firm
Hospira Inc.
Manufacturer
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
275 N Field Dr, N/A, Lake Forest, Illinois 60045-2579

Distribution

Quantity
95,700 vials
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2013-05-16
FDA classified
2013-05-31
Posted by FDA
2013-06-12
Terminated
2014-11-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-501-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Diazepam · FDA Drug Recalls